The aim is to To upgrade analytic workup of the current extreme intense respiratory condition Covid 2 (SARS‐CoV‐2) pandemic, we deliberately evaluated neurological and neuroradiological indications of SARS‐CoV‐2 and all other known human Covid species (HCoV). Which exercises would we be able to learn? We distinguished applicable distributions (until 26 July 2020) utilizing precise pursuits in PubMed, Web of Science, and Ovid EMBASE with predefined search strings. A sum of 4571 extraordinary distributions were recovered, out of which 378 distributions were chosen for in‐depth examination by two raters, including a sum of 17549 (out of which were 14418 SARS‐CoV‐2) patients. Neurological complexities and related neuroradiological signs are common for all HCoVs (HCoV‐229E, HKU1, NL63, OC43, Middle East respiratory condition (MERS)‐CoV, SARS‐CoV‐1, and SARS‐CoV‐2). Besides there are likenesses in symptomatology across various HCoVs, especially somewhere in the range of SARS‐CoV‐1 and SARS‐CoV‐2. The point of this investigation was to efficiently sum up neurological and neuroimaging signs of all known HCoVs to give prospects to foresee short‐ and long‐term neurological inconveniences of COVID‐19. The fundamental speculation was that there are likenesses, specifically somewhere in the range of SARS‐CoV‐1 and SARS‐CoV‐2, that can help direct our current and future diagnostics of neurological difficulties to limit the long‐term impacts of the current SARS‐CoV‐2 pandemic.
Reference link- https://onlinelibrary.wiley.com/doi/10.1002/acn3.51166
